1467-7652/asset/PBI_left.gif?v=1&s=c6ba661f15cc5ace1a65ccfc38eca2e01487e625)
1467-7652/asset/PBI_right.gif?v=1&s=811856ca54b72291c9d23ab29d1c91b988982114)
Research Article
Utility of the P19 suppressor of gene-silencing protein for production of therapeutic antibodies in Nicotiana expression hosts
Article first published online: 17 SEP 2012
DOI: 10.1111/j.1467-7652.2012.00742.x
© 2012 The Authors Plant Biotechnology Journal © 2012 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd
Additional Information
How to Cite
Garabagi, F., Gilbert, E., Loos, A., McLean, M. D. and Hall, J. C. (2012), Utility of the P19 suppressor of gene-silencing protein for production of therapeutic antibodies in Nicotiana expression hosts. Plant Biotechnology Journal, 10: 1118–1128. doi: 10.1111/j.1467-7652.2012.00742.x
Publication History
- Issue published online: 5 NOV 2012
- Article first published online: 17 SEP 2012
- Manuscript Accepted: 8 AUG 2012
- Manuscript Revised: 1 AUG 2012
- Manuscript Received: 15 MAR 2012
- Abstract
- Article
- References
- Supporting Information
- Cited By
| Filename | Format | Size | Description |
|---|---|---|---|
| pbi742-sup-0001-FigureS1.pptx | application/ | 311K | Figure S1 Western blot (top) and Coomassie-stained gel (bottom) showing the heavy chain of purified trastuzumab from a 21-day time-course with 103 mAb + P19 in ΔXTFT N. benthamiana. |
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.